Literature DB >> 9449931

Cancer statistics, 1998.

S H Landis1, T Murray, S Bolden, P A Wingo.   

Abstract

The Surveillance Research Program of the American Cancer Society's Department of Epidemiology and Surveillance reports its 32nd annual compilation of cancer incidence, mortality, and survival data for the United States and around the world.

Entities:  

Mesh：

Year:  1998        PMID： 9449931     DOI： 10.3322/canjclin.48.1.6

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


  282 in total

1.  Pilot study of a point-of-use decision support tool for cancer clinical trials eligibility.

Authors:  P P Breitfeld; M Weisburd; J M Overhage; G Sledge; W M Tierney
Journal:  J Am Med Inform Assoc       Date:  1999 Nov-Dec       Impact factor: 4.497

Review 2.  Concurrent chemotherapy and radiation therapy in primary cancer of the cervix.

Authors:  J M Schilder; F B Stehman
Journal:  Curr Oncol Rep       Date:  1999-09       Impact factor: 5.075

Review 3.  Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair.

Authors:  C Y Fan
Journal:  Curr Oncol Rep       Date:  2001-01       Impact factor: 5.075

Review 4.  Salvage therapy for ovarian cancer.

Authors:  A A Garcia
Journal:  Curr Oncol Rep       Date:  1999-09       Impact factor: 5.075

Review 5.  Chemotherapy in non-small cell lung cancer.

Authors:  C J Sweeney; A B Sandler
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

6.  Screening for lung cancer: can it be cost-effective?

Authors:  O S Miettinen
Journal:  CMAJ       Date:  2000-05-16       Impact factor: 8.262

7.  Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.

Authors:  M J Page; B Amess; R R Townsend; R Parekh; A Herath; L Brusten; M J Zvelebil; R C Stein; M D Waterfield; S C Davies; M J O'Hare
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 8.  Detection of early lung cancer.

Authors:  J C Porter; S G Spiro
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

9.  Misinterpretation of the chest x ray as a factor in the delayed diagnosis of lung cancer.

Authors:  P M Turkington; N Kennan; M A Greenstone
Journal:  Postgrad Med J       Date:  2002-03       Impact factor: 2.401

10.  K-Ras-independent effects of the farnesyl transferase inhibitor L-744,832 on cyclin B1/Cdc2 kinase activity, G2/M cell cycle progression and apoptosis in human pancreatic ductal adenocarcinoma cells.

Authors:  S Y Song; I M Meszoely; R J Coffey; J A Pietenpol; S D Leach
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.